China Pharma Holdings (CPHI) Non-Current Assets (2010 - 2026)

China Pharma Holdings' Non-Current Assets history runs 17 years deep, the most recent figure standing at $43.1 million for Q1 2026.

• Quarterly Non-Current Assets rose 279.55% year-over-year to $43.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $96.3 million (up 124.04% YoY) and the FY2025 annual result came in at $28.7 million, up 146.64% from the prior year.
• Non-Current Assets was $43.1 million for Q1 2026 at China Pharma Holdings, up from $28.7 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $43.1 million in Q1 2026 and bottomed at $9.5 million in Q3 2023.
• A 5-year average of $14.0 million and a median of $11.3 million in 2023 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2022 — Non-Current Assets retreated 24.53% — and 2026, when it soared 279.55%.
• China Pharma Holdings' Non-Current Assets stood at $11.8 million in 2022, then retreated by 11.4% to $10.5 million in 2023, then increased by 10.93% to $11.6 million in 2024, then soared by 146.64% to $28.7 million in 2025, then surged by 50.56% to $43.1 million in 2026.
• Business Quant data shows CPHI's Non-Current Assets at $43.1 million in Q1 2026, $28.7 million in Q4 2025, and $13.5 million in Q3 2025.